Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.

MLA

Tao, Sibei, et al. “Understanding the Gut–kidney Axis among Biopsy-Proven Diabetic Nephropathy, Type 2 Diabetes Mellitus and Healthy Controls: An Analysis of the Gut Microbiota Composition.” Acta Diabetologica, vol. 56, no. 5, May 2019, pp. 581–92. EBSCOhost, https://doi.org/10.1007/s00592-019-01316-7.

APA

Tao, S., Li, L., Li, L., Liu, Y., Ren, Q., Shi, M., Liu, J., Jiang, J., Ma, H., Huang, Z., Xia, Z., Pan, J., Wei, T., Wang, Y., Li, P., Lan, T., Tang, X., Zeng, X., Lei, S., & Tang, H. (2019). Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition. Acta Diabetologica, 56(5), 581–592. https://doi.org/10.1007/s00592-019-01316-7

Chicago

Tao, Sibei, Lingzhi Li, Ling Li, Yuan Liu, Qian Ren, Min Shi, Jing Liu, et al. 2019. “Understanding the Gut–kidney Axis among Biopsy-Proven Diabetic Nephropathy, Type 2 Diabetes Mellitus and Healthy Controls: An Analysis of the Gut Microbiota Composition.” Acta Diabetologica 56 (5): 581–92. doi:10.1007/s00592-019-01316-7.